Pathology Department, Guangdong Women and Children Hospital, Guangzhou City, Guangdong, 510010, PR China.
Surg Today. 2011 Nov;41(11):1575-8. doi: 10.1007/s00595-010-4516-5. Epub 2011 Oct 4.
Bilateral breast carcinoma accounts for approximately 5% of all patients with breast cancer, while neuroendocrine breast carcinomas comprise less than 5% of invasive breast carcinomas. In addition, most patients with breast neuroendocrine carcinomas are older. Therefore, bilateral primary breast neuroendocrine carcinoma at a young age is extremely rare. We herein report bilateral neuroendocrine carcinoma of the breast in a 29-year-old woman who underwent bilateral lumpectomy with the initial symptom of bilateral nipple discharge. Grossly, the lesions in both breasts were masses with infinite margins. Histologically, this case was consistent with primary neuroendocrine carcinoma arising in bilateral breasts. Cells from both breast tumors were positive for chromogranin A, neuron-specific enolase, synaptophysin, cytokeratin 7, estrogen receptor, and progesterone receptor, and negative for Her2, cytokeratin 34β12, cytokeratin 5/6, smooth muscle actin, p63, S-100 protein, and p53. The Ki67 and NE proliferative indices were below 1%. To the best of our knowledge, this is the first reported case in China of bilateral primary neuroendocrine carcinoma presenting in a young woman.
双侧乳腺癌约占所有乳腺癌患者的 5%,而神经内分泌乳腺癌占浸润性乳腺癌的不到 5%。此外,大多数患有乳腺神经内分泌癌的患者年龄较大。因此,年轻患者双侧原发性乳腺神经内分泌癌极为罕见。本文报道了一例 29 岁女性双侧原发性乳腺神经内分泌癌,其首发症状为双侧乳头溢液。大体上,双侧乳房的病变均为边界无限的肿块。组织学上,本例符合双侧乳腺原发性神经内分泌癌。来自两个乳房肿瘤的细胞均对嗜铬粒蛋白 A、神经元特异性烯醇化酶、突触素、细胞角蛋白 7、雌激素受体和孕激素受体呈阳性,而对 Her2、细胞角蛋白 34β12、细胞角蛋白 5/6、平滑肌肌动蛋白、p63、S-100 蛋白和 p53 呈阴性。Ki67 和 NE 增殖指数均低于 1%。据我们所知,这是首例在中国报道的年轻女性双侧原发性神经内分泌癌病例。